Negotiations to secure Janssen COVID-19 vaccine doses could be finalized soon, according to Galvez.
Vaccine czar Secretary Carlito Galvez Jr. said that negotiations to secure around 5 million to 10 million Janssen COVID-19 vaccine doses could be finalized soon.
During the Presidential press briefing on Thursday, Galvez said that they’ll finalize the negotiations to secure 5 million to 10 million Janssen COVID-19 vaccine doses “by the end of this month”.
However, Galvez didn’t give additional details about the negotiations.
To recall, the country’s Food and Drug Administration (FDA) had already approved Janssen Pharmaceuticals’ single-shot COVID-19 vaccine for emergency use.
The said approval came amidst reports that some people in the United States developed rare blood clots after receiving the said vaccine. However, the European Medicines Agency (EMA) on Tuesday said that the benefits of the said vaccine still outweighed the risks.
According to EMA, blood clots should be listed as a “very rare” side effect of Janssen’s COVID-19 vaccine.
Based on a report on GMA News Online, the United States was expected to announce its decision on the said vaccine on Friday as nations around the world urgently tried to revive their pandemic-ravaged economies and to accelerate vaccination campaigns.
“This is a very rare effect. But it also makes it very important for doctors and patients to be aware of the signs so that they can spot any concerns,” EMA chief Emer Cooke told reporters.